Group 1 - The core point of the article is that Jiahua Co., Ltd. announced the convening of its sixth fifth board meeting to review the semi-annual report for 2025 [1] - The meeting took place on August 18, 2025, and was conducted in a hybrid format combining in-person and communication methods [1] - Jiahua Co., Ltd. reported that its revenue composition for the year 2024 is as follows: food accounts for 92.41%, steam and electricity for 7.31%, and other businesses for 0.28% [1] Group 2 - As of the report, Jiahua Co., Ltd. has a market capitalization of 2.4 billion yuan [1]

Core Insights - The company reported a decrease in revenue for the first half of 2025, amounting to approximately 681 million yuan, which represents a year-on-year decline of 12.86% [2] - The net profit attributable to shareholders increased to approximately 62.29 million yuan, reflecting a year-on-year growth of 7.79% [2] - Basic earnings per share rose to 0.38 yuan, marking an increase of 8.57% compared to the previous year [2]

Core Viewpoint - The company plans to distribute a cash dividend of RMB 0.30 per share (including tax) to all shareholders, amounting to a total of RMB 49,365,000, which represents 79.25% of the net profit attributable to shareholders for the first half of 2025 [3][7][19]. Company Overview - The company is named Shandong Jiahua Biotechnology Co., Ltd. and is listed under the stock code 603182 [5][13]. - The total share capital of the company as of June 30, 2025, is 164,550,000 shares [3][7]. Profit Distribution Plan - The proposed cash dividend distribution is based on the total share capital as of the equity distribution registration date, which will be specified in a future announcement [6][19]. - The company’s retained earnings as of June 30, 2025, amount to RMB 445,952,469.52 [7]. - The distribution plan does not require approval from the shareholders' meeting as it falls within the authorization granted at the 2024 annual shareholders' meeting [8][9]. Decision-Making Process - The board of directors approved the profit distribution plan during the sixth board meeting held on August 18, 2025, with unanimous support [10][19]. - The supervisory board also reviewed and approved the profit distribution plan, affirming its alignment with the company's performance and growth potential [11][25].

证券日报网讯 8月19日晚间，嘉华股份发布公告称，公司第六届董事会第五次会议审议通过了《关于 2025年半年度报告及其摘要的议案》等。 （文章来源：证券日报） ...

证券日报网讯 8月19日晚间，嘉华股份发布公告称，公司第六届监事会第四次会议审议通过了《关于 2025年半年度报告及其摘要的议案》等。 （文章来源：证券日报） ...

资金面上看，该股今日主力资金净流出62.60万元，近5日主力资金净流入525.53万元。 按申万行业统计，嘉华股份所属的农林牧渔行业共有7家公司公布了2025半年度分配方案，派现金额最 多的是海大集团，派现金额为3.33亿元，其次是益生股份、立华股份，派现金额分别为1.63亿元、 8372.70万元。（数据宝） 公司上市以来历次分配方案一览 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2025.06.30 | 10派3元（含税） | 0.49 | 2.38 | | 2024.12.31 | 10派1元（含税） | 0.16 | 0.83 | | 2023.12.31 | 10派4元（含税） | 0.66 | 2.39 | | 2022.12.31 | 10派3元（含税） | 0.49 | 1.56 | 证券时报·数据宝统计显示，公司今日公布了半年报，共实现营业收入6.81亿元，同比下降12.86%，实 现净利润6229.12万元，同比增长7.79%，基本每股收益为0.38元，加权平均净资产收益率为5.64%。 | 代码 | 简 ...

Core Insights - The core viewpoint of the article highlights the financial performance of Jia Hua Co., which reported a decline in revenue but an increase in net profit for the first half of 2025 [1] Financial Performance - Jia Hua Co. reported a revenue of 681 million yuan, representing a year-on-year decrease of 12.9% [1] - The net profit attributable to shareholders was 62.29 million yuan, showing a year-on-year increase of 7.8% [1] Business Operations - The company is primarily engaged in the research, production, and sales of soybean protein and related by-products [1] - Despite a complex market environment, the company maintained stable operations in its main business [1] - During the reporting period, Jia Hua Co. actively advanced multiple new investment projects, gradually releasing production capacity, which led to stable growth in the output of its main products [1] Market Challenges - The year-on-year decline in revenue was mainly attributed to the impact of raw material prices, which resulted in a decrease in product sales prices and consequently reduced sales revenue [1]

证券代码：603182 证券简称：嘉华股份 公告编号：2025-019 山东嘉华生物科技股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，山东嘉华生物科技股份有限公司（以下简称"公 司"）现将 2025 年半年度主要经营数据公告如下： | | | 单位：万元 | | --- | --- | --- | | 项目 | 金额 | 比例（%） | | 大豆蛋白 | 39,554.66 | 58.23 | | 大豆油 | 14,944.04 | 22.00 | | 大豆膳食纤维 | 4,158.90 | 6.12 | | 低温食用豆粕 | 2,426.80 | 3.57 | | 蒸汽 | 3,115.44 | 4.59 | | 电力 | 1,666.80 | 2.45 | | 副产品 | 2,067.26 | 3.04 | | 合计 | 67,933.90 | 100.00 | 一、按产品 ...

证券代码：603182 证券简称：嘉华股份 公告编号：2025-021 山东嘉华生物科技股份有限公司 第六届监事会第四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 山东嘉华生物科技股份有限公司（以下简称"公司"）第六届监事会第四次 会议的通知于 2025 年 8 月 8 日以通讯方式发出，会议于 2025 年 8 月 18 日在公 司会议室以现场方式召开。会议应出席监事 3 名，实际出席监事 3 名，监事会主 席贾辉先生主持了本次会议。会议的通知、召集、召开和表决程序符合《中华人 民共和国公司法》等有关法律、法规及《公司章程》的规定。 二、监事会会议审议情况 （一）审议通过《关于 2025 年半年度报告及其摘要的议案》 监事会认为，公司 2025 年半年度报告的编制符合法律、法规、《公司章程》 和公司内部管理制度的各项规定。公司严格按照上市公司财务制度规范运作， 2025 年半年度报告真实、准确地反映了公司 2025 年半年度的财务状况和经营成 果，不存在任何虚假记载、误导性陈述或者重 ...

表决结果：8 票赞成，0 票反对，0 票弃权。 本报告中的相关财务信息已经董事会审计委员会审议通过。 具体内容详见公司于上海证券交易所网站（www.sse.com.cn）及指定信息披 露媒体披露的《2025 年半年度报告》全文及摘要。 证券代码：603182 证券简称：嘉华股份 公告编号：2025-020 山东嘉华生物科技股份有限公司 第六届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 山东嘉华生物科技股份有限公司（以下简称"公司"）第六届董事会第五次 会议的通知于 2025 年 8 月 8 日以通讯方式发出，会议于 2025 年 8 月 18 日在公 司会议室以现场结合通讯方式召开。会议应出席董事 8 名，实际出席董事 8 名， 董事长李广庆先生主持了本次会议，公司监事及高级管理人员列席会议。会议的 通知、召集、召开和表决程序符合《中华人民共和国公司法》等有关法律、法规 及《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于 2025 年半年度报告及其摘要的议 ...